148 related articles for article (PubMed ID: 28063993)
21. Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study.
Ang MJ; Lau QY; Ng FM; Then SW; Poulsen A; Cheong YK; Ngoh ZX; Tan YW; Peng J; Keller TH; Hill J; Chu JJ; Chia CS
J Enzyme Inhib Med Chem; 2016; 31(2):332-9. PubMed ID: 25792507
[TBL] [Abstract][Full Text] [Related]
22. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
23. [Advances in functional studies of nonstructural proteins and development of antiviral agents for enterovirus 71].
Qin XY; Lin L; Yang Y; Zhang SX; Kong JQ; Cheng KD; Zhao YF; Wang W
Yao Xue Xue Bao; 2011 Jul; 46(7):753-61. PubMed ID: 22010343
[TBL] [Abstract][Full Text] [Related]
24. Antiviral effects of Phyllanthus urinaria containing corilagin against human enterovirus 71 and Coxsackievirus A16 in vitro.
Yeo SG; Song JH; Hong EH; Lee BR; Kwon YS; Chang SY; Kim SH; Lee SW; Park JH; Ko HJ
Arch Pharm Res; 2015 Feb; 38(2):193-202. PubMed ID: 24752860
[TBL] [Abstract][Full Text] [Related]
25. Structural characterization and antiviral activity of a novel heteropolysaccharide isolated from Grifola frondosa against enterovirus 71.
Zhao C; Gao L; Wang C; Liu B; Jin Y; Xing Z
Carbohydr Polym; 2016 Jun; 144():382-9. PubMed ID: 27083830
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of enterovirus 71 by adenosine analog NITD008.
Deng CL; Yeo H; Ye HQ; Liu SQ; Shang BD; Gong P; Alonso S; Shi PY; Zhang B
J Virol; 2014 Oct; 88(20):11915-23. PubMed ID: 25100827
[TBL] [Abstract][Full Text] [Related]
27. [Research into the Pathogenicity of Enterovirus 71].
Sun L; Wen H; Wang Z
Bing Du Xue Bao; 2015 Mar; 31(2):192-6. PubMed ID: 26164947
[TBL] [Abstract][Full Text] [Related]
28. The multi-targeted kinase inhibitor sorafenib inhibits enterovirus 71 replication by regulating IRES-dependent translation of viral proteins.
Gao M; Duan H; Liu J; Zhang H; Wang X; Zhu M; Guo J; Zhao Z; Meng L; Peng Y
Antiviral Res; 2014 Jun; 106():80-5. PubMed ID: 24680956
[TBL] [Abstract][Full Text] [Related]
29. Saururus chinensis (Lour.) Baill blocks enterovirus 71 infection by hijacking MEK1-ERK signaling pathway.
Wang C; Wang P; Chen X; Wang W; Jin Y
Antiviral Res; 2015 Jul; 119():47-56. PubMed ID: 25912818
[TBL] [Abstract][Full Text] [Related]
30. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes.
Yi L; He Y; Chen Y; Kung HF; He ML
Antivir Ther; 2011; 16(1):51-8. PubMed ID: 21311108
[TBL] [Abstract][Full Text] [Related]
31. Discovery of gramine derivatives that inhibit the early stage of EV71 replication in vitro.
Wei Y; Shi L; Wang K; Liu M; Yang Q; Yang Z; Ke S
Molecules; 2014 Jun; 19(7):8949-64. PubMed ID: 24979400
[TBL] [Abstract][Full Text] [Related]
32. Discovery of 3-benzyl-1,3-benzoxazine-2,4-dione analogues as allosteric mitogen-activated kinase kinase (MEK) inhibitors and anti-enterovirus 71 (EV71) agents.
Sun J; Niu Y; Wang C; Zhang H; Xie B; Xu F; Jin H; Peng Y; Liang L; Xu P
Bioorg Med Chem; 2016 Aug; 24(16):3472-82. PubMed ID: 27288186
[TBL] [Abstract][Full Text] [Related]
33. Antiviral drug discovery for the treatment of enterovirus 71 infections.
Shang L; Xu M; Yin Z
Antiviral Res; 2013 Feb; 97(2):183-94. PubMed ID: 23261847
[TBL] [Abstract][Full Text] [Related]
34. [Study on the association of hand, foot and mouth disease and enterovirus 71/CA16 among children in Beijing, 2007].
Zhu RN; Qian Y; Deng J; Xing JF; Zhao LQ; Wang F; Liao B; Ren XX; Li Y; Zhang Q; Li J
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):1004-8. PubMed ID: 18399150
[TBL] [Abstract][Full Text] [Related]
35. In vitro inhibition of enterovirus 71 infection with a nickel ion/chitosan microcomposite.
Lin YC; Chang CH
Virus Res; 2014 Sep; 190():17-24. PubMed ID: 24998885
[TBL] [Abstract][Full Text] [Related]
36. Biochemical characterization of recombinant Enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay.
Shang L; Zhang S; Yang X; Sun J; Li L; Cui Z; He Q; Guo Y; Sun Y; Yin Z
Antimicrob Agents Chemother; 2015 Apr; 59(4):1827-36. PubMed ID: 25421478
[TBL] [Abstract][Full Text] [Related]
37. [Observation on virus shedding periods of enterovirus-71 and coxsackievirus A 16 monitored by nucleic acids determination in stool samples of children with hand, foot and mouth disease].
Teng S; Zhao SY; Wei Y; Shao QM; Jiang MY; Cui DW; Xie GL
Zhonghua Er Ke Za Zhi; 2013 Oct; 51(10):787-92. PubMed ID: 24406235
[TBL] [Abstract][Full Text] [Related]
38. Antiviral activity of GuiQi polysaccharides against enterovirus 71 in vitro.
Pu X; Wang H; Li Y; Fan W; Yu S
Virol Sin; 2013 Dec; 28(6):352-9. PubMed ID: 24254889
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
40. Antiviral activity of micafungin against enterovirus 71.
Kim C; Kang H; Kim DE; Song JH; Choi M; Kang M; Lee K; Kim HS; Shin JS; Jeong H; Jung S; Han SB; Kim JH; Ko HJ; Lee CK; Kim M; Cho S
Virol J; 2016 Jun; 13():99. PubMed ID: 27296985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
